Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex.
Level 4 - case-series / case-control
Cross-sectional observational study evaluating biomarker correlations with neuroimaging and symptom severity.
PubMed 31078690 · doi:10.1016/j.bbi.2019.05.011
What was done
Investigators analyzed resting-state functional MRI (rfMRI) data alongside plasma C-reactive protein (CRP) measurements in patients with major depressive disorder exhibiting varying degrees of inflammation. Whole-brain global connectivity and parcellation-based network approaches were applied to map network changes associated with CRP levels. Identified multivariate connectivity features were subsequently evaluated using support vector regression to test whether they could predict depression-related symptoms, specifically anhedonia and psychomotor slowing.
What was found
Elevated plasma CRP was associated with decreased functional connectivity in a distributed network encompassing the ventral striatum, parahippocampal gyrus/amygdala, orbitofrontal cortex, insular cortex, and posterior cingulate cortex, with the ventral medial prefrontal cortex (vmPFC) identified as the central hub. The support vector regression model predicted anhedonia and motor slowing from these connectivity features. The abstract reported no specific quantitative values, sample size, or exact statistical/accuracy metrics.
Why it matters
The study identifies the vmPFC as a key convergence point linking systemic peripheral inflammation to widespread neural network disruption and distinct symptom domains (anhedonia and psychomotor slowing) in major depressive disorder.
Limits
The cross-sectional design cannot determine whether elevated CRP causes altered connectivity or is a secondary correlate. The abstract does not report sample size, demographic details, medication status, effect sizes, or predictive performance statistics. Only one inflammatory marker (CRP) was evaluated rather than a broad cytokine panel.
Cited by
- supports Andy Miller's studies showed that depressed patients with elevated inflammation exhibit distinct brain functional connectivity and different responses to immune agents compared to depressed patients with low inflammation.